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Summary
Four adjacent open reading frames, cytC1–C4, were
cloned from a cytotrienin-producing strain of a Strep-
tomyces sp. by using primers derived from the con-
served region of a gene encoding a nonheme iron
halogenase, CmaB, in coronamic acid biosynthesis.
CytC1–3 were active after expression in Escherichia
coli, and CytC4 was active after expression in Pseudo-
monas putida. CytC1, a relatively promiscuous adeny-
lation enzyme, installs the aminoacyl moieties on the
phosphopantetheinyl arm of the holo carrier protein
CytC2. CytC3 is a nonheme iron halogenase that will
generate both g-chloro- and g,g-dichloroaminobu-
tyryl-S-CytC2 from aminobutyryl-S-CytC2. CytC4, a thi-
oesterase, hydrolytically releases the dichloroamino-
butyrate, a known streptomycete antibiotic. Thus,
this short four-protein pathway is likely the biosyn-
thetic source of this amino acid antimetabolite. This
four-enzyme system analogously converts the proS-
methyl group of valine to the dichloromethyl product
regio- and stereospecifically.
Introduction
In recent studies on the biosynthesis of the coronamic
acid moiety, 1-amino-1-carboxy-2-ethyl cyclopropane,
of the pseudomonal phytotoxin coronatine, we have de-
termined that the cyclopropane ring is constructed by
a cryptic chlorination pathway [1]. Among the novel en-
zymatic features are a nonheme mononuclear iron halo-
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Claremont, California 91711.genase (CmaB) that acts at the unactivated CH3 of an L-
allo-Ile moiety while it is tethered in thioester linkage to
the pantetheinyl arm of a carrier protein, CmaD [1]. The
g-chloro-aminoacyl thioester then is acted on by
CmaC, which generates an a-carbanion equivalent for
intramolecular displacement of the g-Cl, producing the
cyclopropyl aminoacyl scaffold still tethered to the pros-
thetic arm of the carrier protein. The last step is hydro-
lytic release of the coronamic acid, mediated by the
thioesterase CmaT [2].
The ansa-bridged cytotrienin (Figure 1) [3], produced
by a soil bacteria Streptomyces sp. strain, contains
a 1-aminocyclopropane-1-carboxylate (ACC) moiety,
reminiscent of coronamic acid. Feeding studies show
that the ACC moiety in this producer is derived from
the aminobutyryl moiety of L-methionine [4]. In plants,
ACC is biosynthesized from S-adenosylmethionine by
the pyridoxal phosphate (PLP)-dependent ACC syn-
thase [5], and this product serves as a precursor to the
plant hormone ethylene [6]. However, no such pathway
has been detected in prokaryotic microorganisms [4].
To evaluate whether similar logic and enzymatic ma-
chinery to that of coronamic acid biosynthesis is in
play for ACC biogenesis in the cytotrienin producer,
we have used PCR primers homologous to the con-
served sequences in the CmaB halogenase gene to
look for a comparable ORF. Herein, we report the clon-
ing and sequencing of four adjacent ORFs, named
cytC1–C4, as well as their heterologous expression
and functional characterization. CytC1 is a free-standing
adenylation enzyme for amino acids, including amino-
butyrate. CytC2 is a 10 kDa peptidyl carrier protein
that can be primed with phosphopantetheine and
loaded with various amino acids. CytC3 is a mononu-
clear nonheme iron halogenase that can doubly chlori-
nate aminobutyryl-S-CytC2 as well as valyl-S-CytC2 at
the unactivated g-carbon. CytC4 is a thioesterase and
cleaves the product amino acid from the pantetheine
tether. The net action of these four tandemly encoded
proteins is the generation of the known Streptomyces
antimetabolite g,g-dichoroaminobutyrate [7]. Despite
additional sequencing and cloning efforts, no cyclopro-
pane-forming homolog has yet been detected in the
cytotrienin producer.
Results
The CytC Gene Cluster
A gene fragment homologous to cmaB [1, 8] was used to
clone out genes involved in the loading and halogena-
tion of amino acids in this producer. This cloning strat-
egy identified a DNA fragment containing four tandemly
arranged genes, termed cytC1, cytC2, cytC3 (the gene
homologous to cmaB), and cytC4 (Table 1). All of the
protein products represent different nonribosomal pep-
tide synthetase (NRPS) domains. CytC1 is predicted to
function as an adenylation (A) domain, CytC2 as a phos-
phopantetheine (PP)-binding (PCP) domain, CytC3 as
an aliphatic halogenase, and CytC4 as a thioesterase
(TE) domain (Figure 2A). CytC3 is homologous to the
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[1, 9–12]. It possesses the key active site residues char-
acteristic of this class of enzyme (Figure 2B). The typical
carboxylate ligand of nonheme iron hydroxylases is re-
placed by an alanine, the key feature of the nonheme
iron halogenases. The replacement of the carboxylate li-
gand by an alanine allows for the binding of exogenous
chloride to the iron, as shown in the crystal structure of
the syringomycin halogenase SyrB2 [12, 13].
Substrate Specificity of CytC1
Most A domains in NRPS modules are highly specific for
one amino acid. For example, CmaA, which is an A and
T didomain protein involved in coronamic acid biosyn-
thesis, has high specificity for L-allo-Ile and accepts
other aliphatic amino acids with less than 8% efficiency
when compared to L-allo-Ile [1]. Several A domains that
activate aliphatic amino acid substrates have a slightly
broader specificity. For example, LicC from lichenysin
synthetase accepts not only L-Ile, but also L-Leu and
L-Val [14]. It is known that the substrate specificity of
NRPS A domains is determined by the 8 residues around
the substrate-binding pocket [15]. No direct similarity of
Figure 1. Cytotrienin A and Cytotrienin Bthese key residues in CytC1 with other A domains was
observed. However, this set is most similar to residues
in those A domains that activate L-Val, L-Ile, and L-Leu.
CytC1 might therefore prefer aliphatic amino acids.
The His-tagged CytC1 was overproduced in Escheri-
chia coli as a soluble protein and was purified by using
the Ni-NTA resin. The first half-reaction of CytC1, the
reversible formation of aminoacyl-AMP, was followed
by amino acid-dependent exchange of 32PPi into ATP
(Table 2). CytC1 activated different amino acids in the
following order of specificity: L-Val > ACC > D-Aba > D-
Val > 4-Cl-L-Aba > L-Aba > L-allo-Ile w D-Cys > L-Cys >
L-Ilew L-Leu. Only two other proteinogenic amino acids,
L-Thr and L-Ala, were slightly activated by CytC1 (23%
and 5% of the L-Aba rate, respectively). All other protei-
nogenic amino acids were tested and showed rates of
0.1%–0.8% when compared to L-Aba. The surprising
ability of both D-Val and D-Aba to be activated to the
aminoacyl-AMP as well or even better than the L-isomer
does have a precedent in the activation of both L- and
D-Phe by the first module of tyrocidine synthetase
[15, 16]. ACC with Ca substituents mimicking both an
D and an L center has a rate ofw25% of that of the best
substrate, L-Val, in this first half of the CytC1 reaction.
Loading of Amino Acids onto CytC2
The second half-reaction of CytC1 is the transfer of the
activated amino acid (aminoacyl-AMP) to the phospho-
pantetheinyl moiety of the T domain CytC2. N-terminally
His-tagged CytC2 overproduced in E. coli was obtained
as a soluble protein and was purified by using the Ni-
NTA resin. The holo (phosphopantetheinylated) form of
the T domain was generated in situ via the action of
phosphopantetheinyl transferase Sfp [17] on purified
CytC2. Using universally labeled 3H-coenzyme A, incor-
poration of the radiolabel into CytC2 was monitored, and
it was demonstrated to reach a plateau within 5 minTable 1. Designations and Functions of the Genes Inserted in pSPHE02
Predicted
Polypeptide
Amino
Acids/MW
(kDa) Predicted Function
Most Homologous
Gene (Organism) E Value
Homologous
Genes in
S. avermitilisa
Homologous
genes in
S. coelicolora
Orf1 708/75.4 Nitrate reductase catalytic
subunit
Nitrate reductase catalytic subunit
(Amycolatopsis mediterranei)
0 SAV2330 SCO2473
Orf2 462/48.4 Nitrate extrusion protein Putative nitrate extrusion protein
(Streptomyces avermitilis)
e2109 SAV5119 SCO2959
Orf3 329/33.9 Unknown Hypothetical transport protein
yyaM (Bacillus subtilis)
3e218 NE NE
CytC1 524/56.8 NRPS adenylation domain —b — — —
CytC2 87/9.42 NRPS PP-binding domain —b — — —
CytC3 319/36.4 Nonheme iron halogenase Nonheme iron halogenase SyrB2
(Pseudomonas syringae pv.
Syringae)
e2100 NE NE
CytC4 244/25.9 NRPS thioesterase domain Putative thioesterase SAV3201
(Streptomyces avermitilis)
2e216 SAV3201 SCO6287
Orf4 315/33.6 ABC-type sugar transporter Putative transport system integral
membrane protein SAV2145
(Streptomyces avermitilis)
e2114 SAV2145 SCO6086
Orf5 284/30.6 ABC-type sugar transporter Putative transport system integral
membrane protein SCO6087
(Streptomyces coelicolor A3(2))
5e299 SAV2144 SCO6087
Based on predicted amino acid sequences, the putative functions of the predicted proteins are shown with homologous genes. NE: no homol-
ogous gene with an E value less than e210.
a Most homologous genes of Streptomyces avermitilis MA-4680 and S. coelicolor A3(2).
b Homologous genes are not listed because too many genes are found in the database.
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(A) Nine predicted ORFs are shown with restriction sites: E, EcoRI; S, SphI; M, MluI; and X, XhoI. Four of the genes, cytC1, cytC2, cytC3, and
cytC4, are part of the NRPS system. The predicted amino acid sequence of orfx was homologous to NADPH-dependent nitrate reductases,
although several nucleotides remain unknown (indicated with a broken line). The proposed function of each ORF is given in Table 1.
(B) Sequence alignment of CytC3 with other known iron/aKG-dependent halogenases and one hydroxylase showing only the iron coordination
motif. SyrB2 is involved in syringomycin biosynthesis [9], BarB1 and BarB2 are involved in barbamide biosynthesis [10], CmaB is involved in
coronamic acid biosynthesis [1], and FIH-1 [32] is a nonheme iron/aKG asparaginyl hydroxylase. Ala120 in CytC3 is strictly conserved in the
halogenase class and replaces the conserved aspartate ligand in the hydroxylases.when 7 mol% Sfp was used. Therefore, apo-CytC2
could be efficiently modified by Sfp to form holo-CytC2.
The holo-CytC2 peak was observed at 13.8 min by
HPLC. In the presence of CytC1 and various amino
acids, a new peak was observed atw13.2 min. To con-
firm that the new peak corresponded to aminoacyl-
CytC2, the peak was fractionated and analyzed by
MALDI-TOF MS. Apo- and holo-CytC2 were also ana-
lyzed by this method. Apo-CytC2 was observed at m/z
11454.0, and the holo form at m/z 11794.0, consistent
with the theoretical molecular weight (MW) of N-termi-
nally His-tagged protein lacking the first methionine (ex-
pected MW 11,453.2 Da), which is commonly removed
during overproduction in E. coli. Holo-CytC2 was ob-
served at 340 Da higher than the apo form, and various
aminoacylated forms were observed (for example,
L-Val-CytC2: calculated 11,893.8, found 11,895.0;
L-Thr-CytC2: calculated 11,895.8, found 11,896.1; L-
Leu-CytC2: calculated 11,907.9, found 11,906.3).
Mono- and Dihalogenation of L-Aba
and L-Val by CytC3
To evaluate the activity of CytC3, the enzyme was re-
moved from anaerobic storage just prior to incubations
and added to aminoacyl-S-CytC2. In the presence of the
three cosubstrates (O2, aKG, and chloride), halogena-
tion activity was observed with L-Aba-S-CytC2 and
Table 2. Apparent Steady-State Kinetic Parameters of CytC1 for
Different Amino Acids Determined by ATP-32PPi Exchange Assays
Substrate Km (mM) kcat (min
21) kcat/Km (min
21mM21)
L-Val 0.60 6 0.05 17.2 6 0.4 29 6 3
ACC 1.65 6 0.07 11.9 6 0.2 7.2 6 0.4
D-Aba 4.0 6 0.3 17.4 6 0.5 4.3 6 0.4
D-Val 6.9 6 0.5 10.7 6 0.4 1.6 6 0.2
4-Cl-L-Aba 7.6 6 0.6 7.6 6 0.3 1.0 6 0.1
L-Aba 13 6 1 10.7 6 0.5 0.8 6 0.1
L-allo-Ile 18 6 3 12 6 1 0.6 6 0.2
D-Cys 47 6 12 29 6 6 0.6 6 0.3
L-Cys 5.2 6 0.7 2.7 6 0.2 0.5 6 0.1L-Val-S-CytC2 as substrates. Given that the product
amino acid is covalently tethered to CytC2, detection
of product involved the previously described release
of the aminoacyl moieties by enzymatic treatment
with a thioesterase [9]. As shown in Figure 3A, the
enzymatic incubation of L-[3H]Aba-S-CytC2 with CytC3
(CytC3:CytC2 ratio of 0.8:1) gave both 4-Cl-L-[3H]Aba
and 4,4-diCl-L-[3H]Aba product-derived isoindoles
(Figure 3A, trace b). Incorporation of chloride into the
products was shown by using radioactive [36Cl] for
both 4-[36Cl]-L-Aba and 4,4-di[36Cl]-L-Aba (Figure 3A,
trace c). Incubation of CytC3 with D-Aba-S-CytC2,
obtained via loading of CytC2 with CytC1, did not
form any products, arguing in favor of stereo-specific
utilization of L-Aba in this halogenation pathway.
When L-[14C]Val-S-CytC2 was incubated with CytC3
(CytC3:CytC2 ratio of 0.6:1), the major product obtained
was 4,4-diCl-L-[14C]Val, while only a trace amount of
monochlorinated product could be detected (Figure 3B,
trace b), suggesting that valine is a better substrate for
the second halogenation. The identities of the dichlori-
nated amino acids were determined via direct NMR-
spectroscopic analyses of the unfractionated product
mixtures obtained from incubation of L-Aba-S-CytC2
and L-Val-S-CytC2 with CytC3 (CytC3:CytC2 ratio of
0.8:1). Direct NMR-spectroscopic analyses of crude bio-
logical extracts provide a means for their structural
characterization in an unbiased and nondestructive
manner and can be used to identify even minor compo-
nents of complex small-molecule mixtures, often elimi-
nating the need for fractionation and/or derivatization
[18]. The NMR-spectroscopic analyses of the extracts
derived from enzymatic incubation with CytC3 were
based on high-resolution dqf-COSY spectra, which
clearly showed crosspeaks corresponding to the proton
spin systems of 4,4-diCl-L-Aba or 4,4-diCl-L-Val, as well
as signals representing unreacted L-Aba or L-Val, re-
spectively (see the Supplemental Data available with
this article online). In addition, the dqf-COSY spectra of
the crude product mixtures revealed glycerol as well as
ATP, ADP, and AMP as major components, as could be
expected from the incubation protocol. The identity of
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(A) Traces of hydrolyzed amino acid obtained after incubation of L-Aba-S-CytC2 with CytC3. Trace a, radio-HPLC trace of the control reaction
performed with L-[3H]Aba-S-CytC2 in the absence of CytC3. Trace b, radio-HPLC trace of the reaction performed with L-[3H]Aba-S-CytC2,
chloride, O2, aKG, and CytC3. Trace c, radio-HPLC trace of the reaction performed with L-Aba-S-CytC2, O2, aKG, and CytC3 in the presence
of Na[36Cl].
(B) Traces of a hydrolyzed amino acid obtained after incubation of L-Val-S-CytC2 with CytC3. Trace a, radio-HPLC trace of the control reaction
performed with L-[14C]Val-S-CytC2 in the absence of CytC3. Trace b, radio-HPLC trace of the reaction performed with L-[14C]Val-S-CytC2,
chloride, O2, aKG, and CytC3.
(C) Analysis of the amount of L-Aba (diamond) consumed and the amount of 4-Cl-L-Aba (square) and 4,4-diCl-L-Aba (triangle) produced at dif-
ferent ratios of CytC3/CytC2.
(D) Analysis of the amount of L-Val (diamond) consumed and the amount of 4-Cl-L-Val (square) and 4,4-diCl-L-Val (triangle) produced at differ-
ent ratios of CytC3/CytC2.the dqf-COSY crosspeaks assigned to 4,4-diCl-L-Aba
and 4,4-diCl-L-Val was confirmed by direct comparison
with dqf-COSY spectra of authentic synthetic samples.
No other spin systems representing compounds of com-
parable abundance were observed. 4,4-Dichlorination
of both L-Aba and L-Val was further confirmed by coelu-
tion with authentic synthetic samples of 4,4-diCl-L-Val
and 4,4-diCl-L-Aba, as noted in the Experimental Proce-
dures, thus unambiguously demonstrating that both
chlorines are incorporated onto the same carbon
atom. The amount of mono- and dichloroamino acids
produced on CytC2 and released by thioesterase action
was investigated as a function of varying ratios of CytC3
to CytC2 (Figures 3C and 3D). With L-Aba-S-CytC2 as
a substrate, a nearly constant amount of monochlori-
nated product was noted at ratios of 0.4:1 to 1:1. An al-
most linear increase in dichlorination as a function of theamount of added halogenase was observed. The effi-
ciency of dichlorination was especially pronounced
when L-Val was used as the substrate, as the mono-
chloro derivative accumulates only to a small extent.
Furthermore, incorporation of both chlorine atoms to
the pro-S methyl carbon of the valine substrate demon-
strates a remarkable regio- and stereospecificity of ali-
phatic halogenation catalyzed by CytC3.
The gene showing some homology to the coronamic
acid cyclopropane-forming enzyme CmaC [1] was iden-
tified in the draft sequence of the Streptomyces sp.
RK95-74 genome (A. Toyoda et al., personal communi-
cation) and cloned. The protein product was analyzed
for conversion of CytC2-tethered g-Cl-Aba to ACC. No
formation of the desired product was noted (data not
shown). Based on its dimeric structure (MW of 33 kDa)
and homology to other members of the vicinal oxygen
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likely that this streptomycete protein is involved in an al-
ternative epimerase reaction in the producer.
Thioesterase Activity of CytC4
N- and C-terminally His-tagged CytC4 were insoluble
when overproduced in E. coli BL21 (DE3) by using
pET28b or pET37b, respectively, under several condi-
tions, including various incubation temperatures and me-
dia. However, overproduction of N-terminally His-tagged
CytC4 inPseudomonas putidaKT2442 gave soluble pro-
tein. The N-terminally His-tagged CytC4 overproduced in
P. putida was purified by Ni-NTA chromatography.
An initial evaluation of the thioesterase substrate
specificity of CytC4 is shown in Table 3. CytC4 has
a higher specificity for 4-Cl-L-Aba-S-CytC2 and L-Aba-
S-CytC2 than ACC-S-CytC2. CytC4 has an 81-fold lower
specificity for L-Val when compared to L-Aba, whereas
CytC1 has a 36-fold higher specificity for L-Val when
compared to L-Aba.
Antibiotic Activity of 4,4-DiCl-L-Aba
and 4,4-DiCl-L-Val
4,4-DiCl-L-Aba (armentomycin) has previously been iso-
lated from a Streptomyces species and is shown to
have antibitotic activity [7]. Given that we had synthe-
sized the dichlorinated amino acids as standards, we
had sufficient material to evaluate the antibiotic activity
of 4,4-diCl-L-Aba and 4,4-diCl-L-Val against E. coli
strains W3110 and Imp2 (strain Imp2 has an improved
membrane permeability). In both cases, no antibiotic ac-
tivity could be detected when the strains were grown in
Luria Bertani medium. However, when the strains were
grown in M9 minimal media with glucose, antibiotic
activity was observed. Using disc assays on plates
(1 mM amino acid added to disc), zones of inhibition of
1 mm and 12 mm were observed for strain W3110 with
4,4-diCl-L-Val and 4,4-diCl-L-Aba, respectively. Zones
of inhibition of 7 mm and 20 mm were observed for strain
Imp2 with 4,4-diCl-L-Val and 4,4-diCl-L-Aba, respec-
tively. This inhibition of growth could be prevented
when L-Leu or L-Ile was added to the media. The minimal
inhibitory concentration of 4,4-diCl-L-Aba was 128 mg/ml
when evaluated in liquid media for strain W3110. For
strain Imp2, the minimal inhibitory concentration was
32 mg/ml and 512 mg/ml for 4,4-diCl-L-Aba and 4,4-
diCl-L-Val, respectively. No antibiotic activity was de-
tected for 4-Cl-L-Val and 4-Cl-L-Aba under comparable
conditions.
Discussion
The existence of the highly functionalized ACC ring in
the apoptosis-inducing streptomycete metabolite CytA
Table 3. Apparent Steady-State Kinetic Parameters of CytC4 for
Different Amino Acids Loaded on CytC2
Substrate Km (mM) kcat (min
21) kcat/Km (min
21mM21)
4-Cl-L-Aba 106 6 7 1020 6 50 10 6 1
L-Aba 80 6 7 470 6 30 5.9 6 0.9
ACC 73 6 6 32 6 2 0.44 6 0.06
L-Val 80 6 4 5.8 6 0.2 0.073 6 0.007[3], an ansa-bridged macrolactone with 1-aminocyclo-
propane-1-carboxylic acid, inspired a search for and
the discovery of the cytC1–4 cluster described in this
work. In particular, we believed that a mononuclear non-
heme iron halogenase might exist and be responsible for
the generation of a 4-chloroaminobutyryl skeleton as
a precursor to ACC. Cyclopropane-containing amino
acids have been found in other biological contexts,
most notably as free ACC for the generation of ethylene
as a signaling hormone in plants [6], but also as the
ethyl-substituted ACC (coronamic acid) in the phyto-
toxin coronatine, produced by several Pseudomonas
syringae strains during growth on plants [1, 20, 21].
While in plants the ACC biosynthetic pathway starts
with S-adenosylmethionione and is catalyzed by a
PLP-dependent ACC synthase [5], no homologous en-
zyme was found in prokaryotic microorganisms [4].
The strategy for enzymatic formation of the aminocar-
boxycyclopropyl ring of coronamic acid is distinct [1].
Rather than using a PLP-mediated amino acid aldimine
as the precursor to a stabilized C2 carbanion, this enzy-
matic strategy relies on the generation of an aminoacyl
thioester to enable stabilization of C2 carbanion. The
required leaving group on the g-carbon of the L-allo-
Ile-S-CmaD substrate is incorporated via chlorination
of the C4 methyl by a nonheme iron halogenase,
CmaB [1].
Based on the premise that Streptomyces could follow
a similar pathway to that of Pseudomonas syringae for
the generation of the cyclopropane moiety, primers de-
rived from the cmaB DNA sequence were designed and
used to probe the genomic DNA of the CytA producer
Streptomyces sp. RK95-74 for homologs. The four-
gene cluster cytC1–C4 was discovered, with CytC1
homologous to free-standing A domains, CytC2 to
free-standing T domains, CytC3 to nonheme iron halo-
genases, and CytC4 to thioesterases. Thus, the CytC1,
CytC2, CytC3, and CytC4 sequences suggest an NRPS
logic, where an amino acid is selected and activated
as an aminoacyl-AMP (A domain), loaded covalently
onto a T domain that has been posttranslationally
primed with phosphopantetheine to create the amino-
acyl-S-T domain intermediate. This intermediate is
then modified by a tailoring enzyme prior to hydrolysis
by a thioesterase. The sequestration of a fraction of
the pool of a proteinogenic amino acid as a covalent
aminoacyl-S-protein species may be a general strategy
by which producer organisms make nonproteinogenic
amino acids for use in secondary metabolism as well
as activate them for incorporation into NRPS assembly
lines [22].
The key enzyme in this study is an aKG-dependent
nonheme iron halogenase CytC3. This enzyme was
purified anaerobically and reconstituted with Fe(II). It
was tested in the halogenation of L-Aba-S-CytC2 and
L-Val-S-CytC2. These substrates were generated quan-
titatively by the action of CytC1 on primed CytC2. The
formed products were released by enzymatic thioester
bond cleavage by using a thioesterase, derivatized on
the amino group with a fluorescent probe, chromato-
graphed by HPLC, and compared to authentic standards.
Using this method, four different chlorinated amino
acids were shown to be formed by the CytC3 halogen-
ase: 4-Cl-L-Aba, 4,4-diCl-L-Aba with L-Aba-S-CytC2 as
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L-Val-S-CytC2 (Figure 4). Interestingly, 4,4-diCl-L-Aba
(called armentomycin) was previously isolated from
a Steptromyces species and was shown to have antibi-
otic activity [7]. The antibiotic activity was confirmed in
this study, and 4,4-diCl-L-Aba was shown to inhibit the
biosynthesis of L-Leu and L-Ile because the antibiotic ac-
tivity could be prevented when either of these two amino
acids was added to the media. These results, together
with strong sequence homology of CytC3 with other
known halogenases [12, 23], including key active site
residues (Figure 2B), validate that the CytC3 is a new,
to our knowledge, member of the nonheme iron halo-
genase family. This class of enzyme requires O2, chlo-
ride, and aKG for their activity. The crystal structure of
SyrB2 showed that the chloride is bound to the iron(II)
of the enzyme at the beginning of the catalytic cycle
[13]. Recent kinetic and spectroscopic studies revealed
that hydrogen atom abstraction from the substrate is
carried out by an Fe(IV)oxo intermediate, resulting in
the generation of the g-CH2
 radical in the substrate
and the Cl-Fe(III)-OH species [13] (D.P.G., E.W. Barr,
C.T.W., J.M. Bollinger, Jr., and C. Krebs, unpublished
data). It is postulated that subsequent transfer of the
chlorine atom to the organic radical leads to the gener-
ation of the C-Cl bond in the product.
It is an open question whether the g-chloroaminobu-
tyryl moiety is cyclized to ACC in the producer organism
or if CytC1–4 are operating to make and release the free
mono- or dichloroamino acids, some of which serve as
antimetabolites. The producer streptomycete has not
yet been successfully transformed with DNA to allow
knockout of any of the genes in the cytC1–C4 cluster
to evaluate if cytotrienin formation is abrogated (M.U.,
unpublished data). No protein with a function homolo-
gous to CmaC (the cyclopropane-forming enzyme in
the coronamic acid cluster) was detected in the cytC
gene cluster or elsewhere in the producer genome
(M.U. and A. Toyoda, unpublished data).
In sum, an NRPS-inspired route for the formation of
chlorinated amino acids in Streptomyces has been de-
scribed. This system consists of four genes: a promiscu-
ous adenylation enzyme, CytC1; the peptidyl carrier pro-
tein CytC2; the nonheme iron halogenase CytC3; and the
thioesterase CytC4. The formed mono- and dichloro in-
termediates can either be utilized as antimetabolites or
perhaps serve as precursors to ACC derivatives by the
action of a cyclopropane-forming enzyme yet to be
found at a different locus in the genome.
Significance
To our knowledge, this work represents the first clon-
ing and analysis of a biosynthetic gene cluster respon-sible for the formation of g-chlorinated amino acids in
an actinomycete. The CytC cluster is composed of four
ORFs: CytC1, an adenylation enzyme; CytC2, a thiola-
tion protein; CytC3, a nonheme iron halogenase; and
CytC4, a thioesterase. The adenylation enzyme was
able to activate various amino acids and load them
onto CytC2, and the CytC3 halogenase was able to
both mono- and dichlorinate L-Aba and L-Val. 4,4-
DiCl-L-Aba (armentomycin) was already shown to be
a naturally occurring antibiotic, an activity that was
confirmed in this study. Engineering of this pathway
could enable the production of a wide variety of regio-
and stereospecifically chlorinated amino acids.
Experimental Procedures
Chemicals
L-[14C]Val (250 mCi/mmol) and [36Cl]NaCl (16 mCi/g Cl) were pur-
chased from American Radiolabeled Chemicals, Inc. L-[3H]Aba (1
Ci/mmol) was purchased from Moravek Biochemicals, Inc., and
[32P]pyrophosphate was purchased from Perkin Elmer Life Sci-
ences, Inc. Thrombin was purchased from Novagen. Norcoronamic
acid and 4-Cl-L-Val were synthesized as described previously [1].
4,4-Dichloro-2-aminobutyric acid (4,4-diCl-Aba) was prepared by
a known procedure [24]. 4-Chloro-2-aminobutyric acid (4-Cl-Aba)
and 4,4-diCl-L-Val were synthesized as described below. All other
chemicals were of analytical grade.
NMR Spectroscopy
All analyses were carried out by using a VARIAN INOVA 600 MHz
NMR spectrometer, equipped with a 5 mm inverse-detection HCN
probe. NMR spectra were acquired at 25C, by using the standard
pulse sequences provided by VARIAN. Spectra of crude enzymatic
samples were acquired by using Shigemi tubes and dissolving the
sample in 220 ml D2O. For the dqf-COSY spectra, the following pa-
rameters were used: acquisition time, 0.6 s; relaxation delay, 1 s;
and 64 increments per ppm of sweep width. Phase cycling was
used for coherence selection, and gradients were used for homo-
spoil during the relaxation delay. Relevant sections of the dqf-
COSY spectra are shown in the Supplemental Data.
Chemical Synthesis of 4-Cl-Aba
Boc-Hse-OtBu was prepared by following the method of Perich [25].
CCl4 (194 ml, 0.35 mmol), followed by a solution of Ph3P (92.4 mg,
0.35 mmol) in CH2Cl2 (0.5 ml), was added to a cooled (0
C) solution
of Boc-Hse-OtBu (48.5 mg, 0.176 mmol) in anhydrous CH2Cl2
(1.5 ml). The solution was warmed to room temperature for 30 min,
then heated in a 40C oil bath for 15 hr. The reaction mixture was
then concentrated in vacuo, triturated with 5:1 hexanes:Et2O, and fil-
tered through a cotton plug. The filtrate was concentrated in vacuo
and chromatographed on silica (7:1 hexanes:Et2O) to give Boc-
(4-Cl)Abu-OtBu (35.0 mg, 68% yield) as a colorless oil that forms
needles when stored at 220C; Rf = 0.2 (5:1 hexanes:Et2O);
1H-
NMR (500 MHz, CDCl3); d = 5.17 (br, 1H), 4.29 (m, 1H), 3.58 (m, 2H),
2.28 (m, 1H), 2.09 (m, 1H), 1.46 (s, 9H), 1.44 (s, 9H); 13C-NMR
(125 MHz, CDCl3); d = 171.2, 155.6, 82.6, 80.1, 52.4, 40.9, 36.1,
28.5, 28.2. Boc-(4-Cl)Abu-OtBu (90.3 mg, 0.307 mmol) was dissolved
in trifluoroacetic acid (1.0 ml) and left at room temperature for 3 hr.
Volatiles were removed with a stream of nitrogen. Exhaustive
concentration in vacuo gave a tan solid (77.0 mg, quantitative yield).
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11894-Cl-Aba was conveniently stored as its trifluoroacetic acid salt; one
equivalent of NaOH was added prior to enzymatic assays. 1H-NMR
(500 MHz, D2O); d = 4.13 (app t, 1H, J = 6.7 Hz), 3.66 (m, 2H),
2.36 (m, 1H), 2.21 (m, 1H); 13C-NMR (125 MHz, D2O); d = 171.8,
51.0, 40.6, 32.9.
Chemical Synthesis of 4,4-DiCl-L-Val
(2S,4R)-2-Amino-3-Methyl-4-Oxo-Butyric Acid
Oxalyl chloride (34 ml, 0.39 mmol) was added dropwise to a cooled
(278C) solution of DMSO (55.2 ml, 0.78 mmol) in anhydrous
CH2Cl2 (2.3 ml). The resulting solution was stirred at this temperature
for 20 min. A cooled (278C) solution of (3R,4S)-N-(tert-Butyldime-
thylsilyl)-3-methyl-azetidin-2-one-4-carboxylic acid tert-butyl ester
(22.5 mg, 0.078 mmol) [1] in anhydrous CH2Cl2 (6.9 ml) was canula
transferred to the reaction mixture. The resulting white suspension
was stirred at 278C for 20 min, and Et3N (162 ml, 1.17 mmol)
was subsequently added. The resulting solution was warmed up to
240C and was stirred at this temperature for 15 min. Water (2 ml)
was added, and the reaction mixture was warmed up to room tem-
perature and partitioned between CH2Cl2 (100 ml) and saturated
aqueous ammonium chloride solution (50 ml). The organic layer
was washed with saturated aqueous sodium bicarbonate (50 ml),
followed by saturated aqueous sodium chloride solution (50 ml),
dried (Na2SO4), and concentrated in vacuo. The residue was purified
by silica gel flash chromatography (5:1 hexanes:EtOAc) to provide
(2S,4R)-2-amino-3-methyl-4-oxo-butyric acid (19.0 mg, 85%) as
a white solid; Rf = 0.66 (5:1 hexanes:EtOAc);
1H-NMR (500 MHz,
CDCl3); d = 9.74 (s, 1H), 5.36 (d, J = 8.30 Hz, 1H), 4.69 (dd, J = 7.81,
3.91 Hz, 1H), 3.09 (m, 1H), 1.50 (s, 9H), 1.48 (s, 9H), 1.17 ppm
(d, J = 7.33 Hz, 3H).
(2S,4R)-2-Amino-4,4-Dichloro-3-Methyl-Butyric Acid
A solution of hydrazine hydrate (65 ml, 1.32 mmol) in MeOH (400 ml)
was stirred at room temperature in the presence of powdered mo-
lecular sieves (95 mg) for 35 min. A solution of (2S,4R)-2-amino-3-
methyl-4-oxo-butyric acid (19.0 mg, 0.066 mmol) in MeOH (900 ml)
was added dropwise, and the resulting suspension was stirred at
room temperature for 2 hr. The resulting solution was filtered, sieves
were washed with Et2O (3 3 1.5 ml), and the filtrate was concen-
trated in vacuo and then under high vacuum to provide the crude
hydrozone.
Triethyl amine (41.0 mL, 0.3 mmol) was added to a solution of dry
copper (II)-chloride (78.0 mg, 0.58 mmol) in anhydrous MeOH
(500 ml), and the resulting suspension was stirred at room tempera-
ture for 10 min. The reaction mixture was subsequently cooled to
0C, and a solution of crude hydrazone in dry MeOH (750 ml) was
added dropwise. The reaction mixture was stirred at this tempera-
ture for 1 hr, and then at room temperature for 50 min. A 3.5% solu-
tion of aqueous ammonia (2 ml) was then added, and the reaction
mixture was partitioned between CH2Cl2 (75 ml) and saturated aque-
ous sodium chloride solution (30 ml). The organic layer was dried
(Na2SO4) and concentrated, and the residue was purified by silica
gel flash chromatography (7:1 hexanes:EtOAc) to provide (2S,4R)-
2-amino-4,4-dichloro-3-methyl-butyric acid (2.3 mg, 10%) as a white
solid; Rf = 0.34 (7:1 hexanes:EtOAc);
1H-NMR (500 MHz, CDCl3); d =
5.94 (d, J = 5.40 Hz, 1H), 5.18 (br. s, 1H), 4.48 (br. s, 1H), 2.59 (br. s,
1H), 1.55 (s, 9H), 1.51 (s, 9H), 1.24 (d, J = 7.81, 3.91 Hz, 1H), 3.09
(m, 1H), 1.50 (s, 9H), 1.48 (s, 9H), 1.24 ppm (d, J = 6.84 Hz, 3H).
4,4-Dichloro-L-Val$TFA
Trifluoroacetic acid was added to a solution of Boc-(4,4-diCl)Val-
OtBu (1.6 mg, 0.005 mmol) in CH2Cl2, and the resulting solution
was stirred at room temperature for 15 hr. The reaction mixture
was concentrated in vacuo to provide (2S,4R)-4,4-diCl-Val$TFA
(1.3 mg, 93%) as a yellowish oil. 1H-NMR (500 MHz, D2O); d = 6.28
(d, J = 8.30 Hz, 1H), 4.21 (d, J = 3.42 Hz, 1H), 2.61 (m, 1H), 1.32 ppm
(d, J = 6.84 Hz, 3H).
Strains and Culture Conditions
Streptomyces sp. RK95-74, the CytA producer, was cultured in Ben-
net’s broth medium at 30C on rotary shaker at 200 rpm. E. coli
TOP10 (Invitrogen) and E. coli BL21 (DE3) (Invitrogen) were grown
in Luria-Bertani (LB) medium at appropriate temperatures. Ampicil-
lin (120 mg/ml) and kanamycin (50 mg/ml) were used for the selection
of E. coli transformants, and tetracycline (20 mg/ml) was used for se-
lections of E. coli and P. putida KT2442 carrying the pVLT31 vector[26]. E. coli W3110 (ATCC 27325) and E. coli Imp2 [27] were used to
investigate the antibiotic activity of chlorinated amino acids in LB
and M9 minimal media.
DNA Manipulation and Southern Hybridization
Agarose gel electorophoresis and restriction enzyme digestion were
performed by following standard procedure [28]. DNA probes for
Southern hybridization were labeled with alkaline phosphatase,
and hybridization signals were generated by using the AlkPhos Di-
rect Labeling and Detection System with CDP-Star (GE Healthcare)
according to the manufacturer’s instructions.
Computational Analyses
Alignment of primary sequence data was performed by using the As-
semblyLIGN (Oxford Molecular Group) run on a Macintosh com-
puter. ORFs were predicted by using the FramePlot ([29]; http://
watson.nih.go.jp/wjun/cgi-bin/frameplot.pl). Basic local alignment
search tool (BLAST) analyses were performed at the National Center
for Biotechnology Information web site (http://www.ncbi.nlm.
nih.gov/).
Cloning of the DNA Fragment Containing the CytC Cluster
A designated PCR primer pair was used to amplify a fragment ho-
mologous to a portion of cmaB from the total DNA of RK95-74.
The pair consisted of CMB1F (50-ACCTACGACCGSCACCTSG
AC-30; S = G or C) and CMB2R (50-GCCTGGTGCCAGTCSGTSCC-
30). These primers were designed based on alignment analysis of
CmaB (NCBI protein ID: AAQ93485), BarB1 (AAN32975), and
BarB2 (AAN32976), which are involved in barbamide biosynthesis
by the cyanobacteria Lyngbya majuscula, and SyrB2 (AAD50521),
which is involved in syringomycin biosynthesis byPseudomonas sy-
ringae pv. syringae. PCR with this primer pair was performed, and
the amplified fragments (w160 bp) were purified in agarose gel
and ligated into the TA cloning vector pGEM-T Easy (Promega). Se-
quence analysis and its predicted amino acids showed that the frag-
ment had 66% identity to CmaB and 77% identity to SyrB2. Using
this fragment as a probe, southern hybridization against completely
digested total DNA of strain RK95-74 with several restriction en-
zymes was performed with nylon transfer membrane Hi-bond N+
(GE Healthcare) and the AlkPhos detection kit (GE Healthcare) ac-
cording to the manufacturer’s instructions. The probe hybridized
to 15–20 kbp SphI-digested fragments. The fragments were ex-
tracted from agarose gel, followed by ligation into pUC19. About
300 clones were probed by using the alkaline phosphosphatase-
labeled fragment. One of clones, SPHE02, was hybridized with the
labeled probe, and the plasmid pSPHE02 was extracted from the
clone. The inserted fragment was then sequenced. Automated
DNA sequencing was performed on ABI Prism 3100 and 3730 DNA
sequencers at the DNA sequencing facility of the Dana-Farber Can-
cer Institute (Boston, MA).
Subcloning, Overproduction, and Purification of N-Terminal
His-Tagged CytC1 and CytC2
Two sets of PCR primer pairs were used to amplify cytC1 and cytC2
genes from pSPHE02. One set consisted of CYTC1F (50-GGTTTC
CCCATATGCTGCTGCAATC-30; restriction site is underlined) and
CYTC1R (50- CCCAAGCTTCATCATGAACGTGCCACC-30) to amplify
cytC1, and the other set consisted of CYTC2F (50- GGTGGCACGCA
TATGACGGGACAGC-30) and CYTC2R (50-CCCAAGCTTCTACTAC
TTGGTGGACCG-30) to amplify cytC2. These primers were designed
to introduce an NdeI restriction site on the forward strand and a Hin-
dIII site on the complementary strand into amplified fragments. After
PCR amplification with Pfu Turbo DNA polymerase, resulting prod-
ucts of the w1.6 kbp cytC1 and the w290 bp cytC2 were purified
by agarose gel electrophoresis and were digested with NdeI and
HindIII. The digested fragments were purified as described above
and ligated into NdeI- and HindIII-digested pET28b. After transfor-
mation into E. coli TOP10 (Invitrogen), the expression vectors were
purified and inserts were sequenced by using T7 promoter primers
to confirm sequences. The vectors were transformed into E. coli
BL21 (DE3), and resulting transformants were grown in LB medium
supplemented with 50 mg/ml kanamycin. Six liters of medium were
inoculated with 60 ml of an overnight culture and were incubated
at 37C to an OD600 = 0.7. The incubation temperature was lowered
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of 100 mM isopropyl-b-D-thiogalactopyranoside (IPTG). Cells were
grown for an additional 15 hr at 25C, harvested by centrifugation
(10 min at 6,000 3 g), and resuspended in 40 ml of 25 mM Tris-HCl
(pH 8.0), 400 mM NaCl, 10% glycerol. Cell lysis was performed by
two passages through a French press at 15,000 psi. Cell lysates
were clarified by centrifugation (30 min at 15,000 3 g) and were ap-
plied to 2 ml Ni-NTA agarose resin (Qiagen). After gentle shaking for
2 hr at 4C to bind the desired His-tagged protein, the resin was
washed with 10 ml lysis buffer and then eluted with a step gradient
of lysis buffer containing increasing amounts of imidazole (2, 6, 20,
40, 60, 200, and 500 mM). CytC1 eluted in the 20 and 40 mM imidaz-
ole fractions, and CytC2 eluted with 60 and 200 mM imidazole. Frac-
tions containing CytC1 or CytC2 were dialyzed overnight against
50 mM Tris-HCl (pH 8.0), 100 mM NaCl, 1 mM DTT, 10% glycerol; fro-
zen in liquid nitrogen; and stored at 280C. Protein concentrations
were determined by the Bradford method [30]. Alternatively, the pro-
tein was purified in the apo form and was reconstituted as previously
described [10] after the gel filtration step.
Subcloning, Overproduction, and Purification of CytC3
A pair of PCR primers was used to amplify the cytC3 gene from
pSPHE02. The pair consisted of CYTC3F (50-GAGAATCCATATGAC
CACTGTGAGC-30) and CYTC3R (50-CCCAAGCTTCATCATGAACGT
GCCACC-30). The amplified product (w1.0 kbp) was digested with
NdeI and HindIII and was cloned into pET28b. Transformants of
E. coli BL21(DE3) expressing cytC3 were prepared as described
above. When OD600 = 0.6, overproduction of CytC3 was induced
by the addition of 150 mM IPTG for 15 hr at 15C. Six liters of culture
were grown and resuspended in 40 ml of 20 mM 4-(2-hydroxyethyl)-
1-piperazinepropanesulfonic acid (HEPPS) (pH 8.0), 300 mM NaCl,
5 mM imidazole. After two successive passages through a French
press at 15,000 psi, the lysate was placed under a stream of argon
and was clarified by centrifugation at 15,000 3 g for 30 min. After
this step, all handling of CytC3 was performed anaerobically in an
Mbraun Labmaster glovebox as previously described [9]. The super-
natant was added to 3 ml Ni-NTA agarose resin and was stirred for
1 hr. The resin was washed with four column volumes of 20 mM
HEPPS (pH 8.0), 300 mM NaCl, 30 mM imidazole, and bound protein
was eluted with 20 mM HEPPS (pH 8.0), 100 mM NaCl, 200 mM im-
idazole. The eluted fractions were concentrated by using an Amicon
ultrafiltration membrane (Millipore) and were buffer exchanged with
20 mM HEPPS (pH 8.0), 80 mM NaCl. CaCl2 (2 mM) was added, and
the solution was incubated for 3 hr at 19C with thrombin (1 U:10 mg
thrombin:CytC3). The protein solution was then diluted 1:1 with
20 mM Tris (pH 8.0) and was loaded onto a MonoQ 10/100GL column
(GE Healthcare) equilibrated with 20 mM Tris (pH 8.0) (multiple runs
were performed). CytC3 was eluted by using a NaCl gradient of
100–250 mM over 15 column volumes at a flow rate of 4 ml/min.
CytC3 eluted at w200 mM NaCl. CytC3 was then concentrated
and incubated with 2 mM aKG, 600 mM Fe(NH4)2(SO4)2, and 1 mM
DTT, and it was then loaded onto a 26/60 Superdex 75 column equil-
ibrated in 20 mM 4-(2-hydroxyethyl)-1-piperazine-ethanesulfonic
acid (HEPES) (pH 7.5). Eluted CytC3 (monomer) was concentrated,
frozen in liquid nitrogen, and stored at280C. Protein concentration
was determined by the Bradford method [30], and the iron concen-
tration of CytC3 was determined by using Ferene S [31].
Subcloning, Overproduction, and Purification of His-Tagged
CytC4
N- and C-terminal His-tagged CytC4 were completely insoluble
when expressed in E. coli BL21(DE3). A plasmid to overexpress
CytC4 in Pseudomonas was constructed. A pair of PCR primers
was used to amplify the cytC4 gene from pSPHE02. The pair con-
sisted of CYTC4F (50-GGAGGTACATATGACGCCCCGTCCC-30)
and CYTC4R (50-CCCGAAGCTTCATCAAGGAGTACGGCCG-30). The
amplified product (w750 bp) was digested with NdeI and HindIII and
was cloned into pET28b. The resulting plasmid, pET28b-CytC4, was
digested with XbaI and HindIII, and the w850 bp fragment was li-
gated into XbaI- and HindIII-digested pVLT31. After tranformation
into E. coli TOP10, clones carrying pVLT31-CytC4 were selected
on LB agar plates containing 20 mg/ml tetracycline. An overnight cul-
ture of P. putida KT2442 was pelleted at 5,000 rpm, and cells were
washed twice with cold, sterile 1 mM HEPES (pH 7.0). A total of0.5 ml pVLT31-CytC4 was added to the cell pellet, and the mixture
was transferred into a 1 mm-gapped Gene Pulser Cuvette (Bio-
Rad). Electroporation was conducted by using a Gene Pulser II at
400 U, 25 mF, and 1.25 kV, followed by immediate addition of
250 ml SOC medium. After incubation of treated cells at 30C for
1 hr, cells were selected on LB agar plates containing 20 mg/ml tet-
racycline. A 60 ml overnight culture of the transformant was trans-
ferred to 6 liter LB medium supplemented with 89 mM potassium
phosphate buffer (pH 7.00) and 20 mg/ml tetracycline. When OD600
= 0.6, overexpression was induced by the addition of 1 mM IPTG.
After induction at 25C for 15 hr, cells were pelleted by centrifuga-
tion. Purification of CytC4 was performed as described for CytC1
and CytC2.
ATP-32PPi Exchange Assay
ATP-32PPi exchange reactions were carried out at 25
C in 100 ml mix-
tures containing 75 mM Tris-HCl (pH 7.5), 10 mM MgCl2, 5 mM tris(2-
carboxyethyl)phosphine (TCEP; pH 7.0), 5 mM ATP, 1 mM Na32PPi
(5 mCi/mol, Perkin Elmer), 1 mM CytC1, and various concentrations
of amino acids. The reactions were initiated by the addition of
CytC1 and were quenched at appropriate time points by the addition
of 500 ml quenching solution (4.46% tetrasodium pyrophospate and
3.5% perchloric acid) with 1.6% activated charcoal. After vortexing
vigorously, the charcoal was washed twice with quenching solution
not containing charcoal, was resuspended in 500 ml sterile water,
and was transferred to 7 ml Ultima Gold scintillation fluid (Perkin El-
mer). Radioactivity bound to charcoal was counted by using
a LS6500 scintillation counter (Beckman Coulter).
HPLC Analyses of Different Forms of CytC2
Purified CytC2 was 40-phosphopantetheinylated in a reaction con-
taining 75 mM HEPES (pH 8.0), 10 mM MgCl2, 5 mM TCEP (pH
7.0), 100 mM Coenzyme A (CoA), 15 mM CytC2, and 1.0 mM Sfp. After
incubation at room temperature for 1 hr, aminoacylation of the re-
sulting holo-CytC2 was initiated by mixing with an equal volume of
a solution containing 75 mM HEPES (pH 8.0), 10 mM MgCl2, 5 mM
TCEP (pH 7.0), 10 mM ATP, and various concentrations of amino
acids and CytC1. After appropriate incubation times, the reaction
mixtures were analyzed by HPLC (Beckman System Gold) with a Vy-
dac Protein and Peptide column (4.6 mm3 250 mm) at a flow rate of
1.0 ml/min by using the following conditions: A solvent, 0.1 % tri-
fluoroacetic acid (TFA) in water; B solvent, acetonitrile, 20 min linear
gradient of 30%–60% B in A. Aminoacylated-S-CytC2 eluted at
13.2 min, and holo-CytC2 eluted at 13.8 min. To assay CytC4, rates
were determined by evaluating the concentration of holo-CytC2
formed after the hydrolysis of aminoacyl-S-CytC2.
CytC3 Activity Assays
The reaction catalyzed by CytC3 was investigated by incubating the
enzyme with loaded CytC2. Loaded CytC2 was prepared by incubat-
ing holo-CytC2 (80–100 mM) with 15–17.5 mM CytC1, 1.5–2.5 mM
amino acid, and 2.5 mM ATP for 60 min, followed by incubation
with 2 mM aKG and CytC3 for 60 min. Chloride (2 mM) was present
in the reaction mixture. The resulting reactions were transferred to
0.5 ml Ultrafree centrifugal devices; excess amino acids was re-
moved; and protein-bound amino acids were hydrolyzed, derivat-
ized, and analyzed by HPLC as previously described [9]. In all cases,
coelution with authentic standards was achieved.
Supplemental Data
Supplemental Data include the dqf-COSY spectra of synthetic and
enzymatic dichloro-Aba and -Val and are available at http://www.
chembiol.com/cgi/content/full/13/11/1183/DC1/.
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